Does monoclonal antibody treatment for COVID-19 impact short and long-term outcomes in a large generalisable population? A retrospective cohort study in the USA

OBJECTIVES: To explore whether monoclonal antibodies (MAb) administered to high-risk patients with COVID-19 during the first week of illness prevent postacute sequelae of SARS-CoV-2 infection. DESIGN: Retrospective cohort study. SETTING: USA. PARTICIPANTS: A sample of 3809 individuals who received M...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffin, Daniel, McNeil, Chace, Okusa, James, Berrent, Diana, Guo, Yinglong, Daugherty, Sarah E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414114/
https://www.ncbi.nlm.nih.gov/pubmed/37553188
http://dx.doi.org/10.1136/bmjopen-2022-069247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414114/
https://www.ncbi.nlm.nih.gov/pubmed/37553188
http://dx.doi.org/10.1136/bmjopen-2022-069247

Ejemplares similares